Efficacy of Pioglitazone on Macrovascular Outcome in Patients With Type 2 Diabetes

Mise à jour : Il y a 4 ans
Référence : NCT00174993

Femme et Homme

Extrait

The purpose of this study is to determine whether pioglitazone, once daily (QD), can delay the time to death, heart attack, acute coronary syndrome, heart bypass surgery, stroke, leg bypass surgery or amputation in patients with type 2 diabetes.


Critère d'inclusion

  • Diabetes Mellitus


Liens